Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC11461 CU CPT 4a

    TLR3-IN-1

    A TLR3 antagonist
  3. GC14710 Poly(I:C)

    聚肌苷-聚胞苷酸复合物; Polyinosinic-polycytidylic acid

    聚(I:C)是一种合成的双链RNA类似物,是一种免疫刺激剂,可作为最强效的干扰素(IFN)诱导剂。
  4. GC14231 AR-C 102222 iNOS inhibitor
  5. GC12342 NDT 9513727 A competitive antagonist of the C5a receptor
  6. GC15807 L-NIL hydrochloride L-NIL hydrochloride 是一种诱导型 NO 合酶抑制剂,对 miNOS 的 IC50 为 3.3 μM。
  7. GC13982 7-NINA non-selective NOS inhibitor
  8. GC16120 AI-3 Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor
  9. GC12609 PS 1145 dihydrochloride An IKKβ inhibitor
  10. GC16345 Bropirimine

    溴匹立明

    An immunomodulator with diverse biological activities
  11. GC17963 CHPG Sodium salt CHPG 钠盐是一种选择性 mGluR5 激动剂,可通过 BV2 小胶质细胞中的 TSG-6/NF-κB 通路减弱 SO2 诱导的氧化应激和炎症。
  12. GC10564 HQL 79

    4-(二苯基甲氧基)-1-[3-(2H-四氮唑-5-基)丙基]哌啶

    A selective HPGD synthase inhibitor
  13. GC14802 ARL 17477 dihydrochloride Selective nNOS inhibitor
  14. GC12325 BYK 191023 dihydrochloride A selective iNOS inhibitor
  15. GC12205 PD 146176

    NSC168807

    PD 146176 是一种有效的选择性网织红细胞 15-LOX-1 抑制剂。
  16. GC16538 RWJ 21757

    洛索立宾,7-Allyl-8-oxoguanosine; RWJ 21757

    A TLR7 agonist
  17. GC18069 Cardamonin

    小豆蔻明; (E)-Cardamomin; (E)-Alpinetin chalcone

    A chalconoid with anti-inflammatory and anti-tumor activity

  18. GC16057 MNITMT MNITMT 是一种更有效的免疫抑制剂,没有骨髓毒性。
  19. GC16874 Ro 106-9920 An inhibitor of IκBα ubiquitination
  20. GC13563 1400W dihydrochloride

    N-[3-(氨甲基)苄基]乙脒二盐酸盐

    A potent, selective iNOS inhibitor
  21. GC12277 MK 886

    3-[1-(4-氯苄基)-3-叔丁基硫代-5-异丙基吲哚-2-基]-2,2-二甲基丙酸,L 663536

    A potent, selective inhibitor of FLAP
  22. GC10709 BW-B 70C

    BW-B 70C 是一种有效的、选择性的和具有口服活性的花生四烯酸 5-脂氧合酶抑制剂。

  23. GC11609 Nω-Propyl-L-arginine hydrochloride neuronal nitric oxide synthase (nNOS) inhibitor
  24. GC12532 CHPG

    Chlorohydroxyphenylglycine, CHPG

    A potent and selective mGluR5 agonist
  25. GC12166 2-Iminopiperidine hydrochloride

    2-亚氨基哌啶盐酸盐

    iNOS inhibitor
  26. GC13532 S-Isopropylisothiourea hydrobromide

    Sisopropyl ITU, IPTU

    A potent inhibitor of NOS in vitro

  27. GC13765 EIT hydrobromide

    S-乙基异硫脲氢溴酸盐

    A potent inhibitor of NOS
  28. GC15010 AMT hydrochloride

    AMT盐酸盐

    A potent, relatively selective inhibitor of iNOS
  29. GC13427 (S)-Methylisothiourea sulfate

    S-甲基异硫脲半硫酸盐

    A potent non-selective inhibitor of NOS
  30. GC16926 L-NMMA acetate

    N-单甲基-L-精氨酸单乙酸酯,Tilarginine acetate; Methylarginine acetate

    A non-selective NOS inhibitor
  31. GC10385 3-Bromo-7-nitroindazole

    3-溴-7-铌溴呋喃酯

    A potent inhibitor of nNOS
  32. GC17951 2-TEDC

    (E)-2-(噻吩-2-基)乙基2-氰基-3-(3,4-二羟基苯基)丙烯酸酯

    5-, 12-, and 15-lipoxygenase inhibitor
  33. GC12867 L-NIO dihydrochloride L-NIO dihydrochloride 是一种有效、非选择性和 NADPH 依赖性一氧化氮合酶 (NOS) 抑制剂,对神经元 (nNOS)、内皮细胞 (eNOS) 和诱导型 (iNOS) 的 Kis 分别为 1.7、3.9、3.9 μM 。
  34. GC12520 Diphenyleneiodonium chloride

    二苯基氯化碘盐,DPI

    二苯碘铵 (DPI) 氯化物 (DPIC) 作为 NADH/NADPH 氧化酶抑制剂,对 Mtb 和 S. aureus 具有有效的抗菌活性。
  35. GC14352 TAT 14 TAT 14 是一种 14 聚体肽,可作为具有抗炎作用的 Nrf2 激活剂。
  36. GC13200 Pam2CSK4 Biotin 生物素化 Pam2CSK4,一种 Toll 样受体 2/6 激动剂
  37. GC10058 Pam2CSK4 A bacterial lipopeptide and TLR2 agonist
  38. GC16445 Pam3CSK4 Biotin

    Pam3Cys-Ser-(Lys)4-Biotin

    biotinylated Pam3CSK4, a toll-like receptor 1/2 agonist

  39. GC10273 Pam3CSK4

    Pam3Cys-Ser-(Lys)4

    Pam3CSK4 (Pam3CysSerLys4) 是一种合成的三酰化脂肽 (LP) 和 TLR2/TLR1 配体激动剂,EC50 为 0.47 ng/mL。
  40. GC17416 ACHP An inhibitor of IKKβ and IKKα
  41. GC13184 PF 184 PF 184 是一种有效的抑制因子-κB 激酶 2 (IKK-2) 抑制剂,IC50 为 37 nM。
  42. GC17510 Compstatin control peptide

    坎普他汀对照肽

    Compstatin 对照肽是 Compstatin 的阴性对照。
  43. GC12232 BAY-X 1005

    BAY X 1005; DG-031

    BAY-X 1005 (BAY X 1005; DG-031) 是一种具有口服活性的选择性 5-脂氧合酶活化蛋白 (FLAP) 抑制剂。
  44. GC15251 Compstatin

    坎普他汀

    A peptide inhibitor of complement activation
  45. GC16096 PR 39 (porcine) PR 39(猪)是一种富含脯氨酸和精氨酸的天然抗菌肽,是一种非竞争性、可逆的变构蛋白酶体抑制剂。
  46. GC10929 Mastoparan X

    G protein activator peptide

  47. GC15598 Ac2-26 An annexin A1-mimetic peptide
  48. GC14727 CCCP

    羰基氰化氯苯腙,Carbonyl cyanide 3-chlorophenylhydrazone; Carbonyl Cyanide m-Chlorophenylhydrazone

    Carbonylcyanide-3-chlorophenylhydrazone (CCCP) 是一种质子载体,可导致线粒体内膜中的质子梯度解偶联,从而抑制 ATP 合成速率。
  49. GC14731 MTT

    噻唑蓝,MTT; Thiazolyl Blue Tetrazolium bromide; Methylthiazolyldiphenyl-tetrazolium bromide

    A cell-permeable and positively charged tetrazolium dye

  50. GC12203 L-Glutathione Reduced

    还原型谷胱甘肽; GSH; γ-L-Glutamyl-L-cysteinyl-glycine

    Nucleophilic co-substrate to glutathione transferases and electron donor to glutathione peroxidases

  51. GC10519 Ethacrynic acid - d5 An internal standard for the quantification of ethacrynic acid

Items 3951 to 4000 of 4267 total

per page

Set Descending Direction